A worldwide leader in injectable drug administration will be the newest company to set up shop in Greenfield, and anticipates ...

Alliance brings together complementary strengths in commercialization strategy, cross-functional launch readiness, ...

With partner Eli Lilly’s help, the radiopharmaceutical drugmaker priced one of the sector’s largest new stock offerings in ...

AirNexis has handed over $40 million cash for Haisco’s HSK39004, coded by AirNexis as AN01. Under the terms of the deal, ...

After a prolonged funding chill, investors say 2026 is shaping up for continued dealmaking and diversified bets beyond ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

Companies are facing a situation where they need to fill their pipelines, but also navigate a competitive environment for the ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA) is one of the best performing pharma stocks in 2025. Truist lifted the ...

Biotech Showcase™ Provides Private and Micro- to Mid-Cap Public Company Executives One-Stop Access to Investors, Pharma ...

Biotech shares have fallen while cash has flowed into oil stocks following the U.S.’s seizing of Venezuelan President Nicolás ...

Merck is in talks to buy cancer drug developer Revolution Medicines in a $28 billion to $32 billion deal, the Financial Times ...